HighGravityData
Companies / Intel / Filing

Intel — Apr 24, 2025 release

Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000050863-25-000070
Open on SEC.gov ↗
Showing in the filing
GAAP additions to property, plant and equipment (gross capital expenditures)
“$18.0”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 19
Revenue for Q2 FY2025
“$11.2 billion to $12.4 billion”
EPS attributable to Intel (GAAP) for Q2 FY2025
“$(0.32)”
Non-GAAP EPS attributable to Intel for Q2 FY2025
“$0.00”
Non-GAAP operating expense target for FY2025
“approximately $17 billion”
Non-GAAP operating expense target for FY2026
“$16 billion”
Gross capital expenditures target for FY2025
“$18 billion”
Net capital expenditures for FY2025
“approximately $8 billion to $11 billion”
Gross Margin (GAAP) for Q2 FY2025
“34.3%”
Gross Margin (Non-GAAP) for Q2 FY2025
“36.5%”
Tax Rate (GAAP) for Q2 FY2025
“(51)%”
Earnings (Loss) Per Share Attributable to In… for Q2 FY2025
“$(0.32)”
Tax Rate (Non-GAAP) for Q2 FY2025
“12%”
Earnings (Loss) Per Share Attributable to In… for Q2 FY2025
“$0.00”
GAAP additions to property, plant and equipm… for FY2025
“$18.0”
Non-GAAP net capital expenditures for FY2025
“$8.0 - $11.0”
GAAP R&D and MG&A for FY2025
“$19.9”
GAAP R&D and MG&A for FY2026
“$19.0”
Non-GAAP R&D and MG&A for FY2025
“$17.0”
Non-GAAP R&D and MG&A for FY2026
“$16.0”
Exhibit 99.1 · the passage around this item
… earlier in the release
Please refer to "Explanation of Non-GAAP Measures" in this document for a detailed explanation of the adjustments made to the comparable US GAAP measures, the ways management uses the non-GAAP measures, and the reasons why management believes the non-GAAP measures provide useful information for investors. (In Billions; Unaudited) Full-Year 2025 Full-Year 2026 Approximately Approximately GAAP additions to property, plant and equipment (gross capital expenditures) $ 18.0   Proceeds from capital-related government incentives (3.0 - 5.0) Partner contributions, net (4.0 - 5.0) Non-GAAP net capital expenditures $8.0 - $11.0 GAAP R&D and MG&A $ 19.9   $ 19.0   Acquisition-related adjustments (0.1) (0.1) Share-based compensation (2.8) (2.9) Non-GAAP R&D and MG&A $ 17.0   $ 16.0   Contacts: Kylie Altman Investor Relations 1-916-356-0320 kylie.altman@intel.com Sophie Metzger Media Relations 1-408-653-0475 sophie.metzger@intel.com
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.